FDA recall, , Moderate risk
Fei Fah Ultra Strentgh Electric Midicated Balm
The product has CGMP deviations.
Summary by Recall Canary from the FDA notice
What happened
Fei Fah Medical Manufacturing Pte. Ltd. of Singapore, Singapore is voluntarily recalling Ultra Strentgh, ELECTRIC MIDICATED BALM (menthol 16% and methyl salicylate 32%) because of CGMP deviations. The recall affects 171,120 units distributed nationwide within the U.S. The product is packaged in a) Net 2.45 oz (70g) and b) 10g sizes, manufactured by Fei Fah Medical Mfg Pte Ltd, Singapore, with U.S. Distributor SOLISTICE MEDICINE COMPANY, 215 West Ann Street, Los Angeles, CA 90012.
The company began the recall on October 23, 2026, and customers were notified by letter. The FDA added the recall to its Enforcement Report on October 27, 2026, and it was in the FDA's weekly enforcement report on November 4, 2026.
What to do
The FDA notice gives no instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the list below, then check the codes the FDA notice also names.
An NDC (National Drug Code) is usually printed on the drug's label.
Ultra Strentgh, Electric Midicated Balm
- NDC
- 63299-001-01
- 63299-001-02
- Lot code
- 23FEBU7001-019
- 24FEBU7001-020
- 23FEBU1001-9
- 24FEBU1001-004
From the FDA notice
ULTRA STRENTGH, ELECTRIC MIDICATED BALM (menthol 16% and methyl salicylate 32%) packaged in a) Net 2.45 oz (70g) (NDC 63299-001-01) and b) 10g (NDC 63299-001-02), Manufactured by Fei Fah Medical Mfg Pte Ltd, Singapore, U.S Distributor: SOLISTICE MEDICINE COMPANY, 215 West Ann Street, Los Angeles, CA 90012
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Oct 26, 2026
- Sold in
Nationwide within the U.S
- Recalled by
- Fei Fah Medical Manufacturing Pte. Ltd.Singapore, Singapore
- Hazard
- Manufacturing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100211
- Recall number
- D-0104-2027
- Quantity recalled
- 171,120 units
- Recall type
- Voluntary: Firm initiated
- How the company first told customers
- Letter
All recalls from Fei Fah Medical Manufacturing Pte. Ltd.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Fei Fah Medical Manufacturing Pte. Ltd. began the recall
FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)
Added to Recall Canary
Summary updated
